Cardiovasc Diabetol. 2024 Dec 21;23(1):452.doi: 10.1186/s12933-024-02545-z. (IF:8.57).

中文速读

在肥胖相关房颤研究中,使用Entranster-R4000转染siRNA沉默ANXA1,探讨ANXA1-FPR2轴通过AMPK通路减轻脂质过载引起的心肌细胞损伤。

大鼠siRNAneonatal rat cardiomyocytes

本文使用:小核酸转染试剂Entranster™-R4000

查看产品详情(含全部 223 篇文献) →

ANXA1-FPR2 axis mitigates the susceptibility to atrial fibrillation in obesity via rescuing AMPK activity in response to lipid overload

Affiliations

Affiliations

  • 1 Department of Cardiology, The Second Affiliate Hospital of Xi’an Jiaotong University, No.157, Xiwu Road, Xincheng District, Xi’an, 710004, Shaanxi, China.
  • 2 Department of Endocrinology, The First Affiliate Hospital of Xi’an Jiaotong University, Xi’an, China.
  • 3 Department of Cardiology, Sir Run Run Shaw Hospital, Hangzhou, China.
  • 4 Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • 5 Department of Cardiology, The Second Affiliate Hospital of Xi’an Jiaotong University, No.157, Xiwu Road, Xincheng District, Xi’an, 710004, Shaanxi, China. wht506@126.com.
  • 6 Xi’an Key Laboratory of Special Medicine and Health Engineering, School of Life Sciences, Northwestern Polytechnical University, No. 127 Youyixi Road, Beilin District, Xi’an, 710072, Shaanxi, China. xinghuaqin@nwpu.edu.cn.
  • 7 Department of Cardiology, The Second Affiliate Hospital of Xi’an Jiaotong University, No.157, Xiwu Road, Xincheng District, Xi’an, 710004, Shaanxi, China. zhengqiangsun@126.com.
# Contributed equally.

Abstract

Atrial fibrillation (AF) is the most prevalent arrhythmia in clinical practice, and obesity serves as a significant risk factor for its development. The underlying mechanisms of obesity-related AF remain intricate and have yet to be fully elucidated. We have identified FPR2 as a potential hub gene involved in obesity-related AF through comprehensive analysis of four transcriptome datasets from AF patients and one transcriptome dataset from obese individuals, and its expression is up-regulated in both AF and obese individuals. Interestingly, ANXA1, the endogenous ligand of FPR2, was found to exhibit differential expression with AF and obesity. Specifically, it was observed to be down-regulated in AF patients but up-regulated in obese individuals. The susceptibility to AF in obese mice induced by high-fat diet (HFD) was increased following with the FPR2 blocker Boc-2.The administration of exogenous ANXA1 active peptide chain Ac2-26 can mitigate the susceptibility to AF in obese mice by attenuating atrial fibrosis, lipid deposition, oxidative stress injury, and myocardial cell apoptosis. However, this protective effect against AF susceptibility is reversed by AAV9-shAMPK-mediated AMPK specific knockdown in the myocardium. The vitro experiments demonstrated that silencing ANXA1 exacerbated lipid deposition, oxidative stress injury, and apoptosis induced by palmitic acid (PA) in cardiomyocytes. Additionally, Ac2-26 effectively mitigated myocardial lipid deposition, oxidative stress injury, and apoptosis induced by PA. These effects were impeded by FPR2 inhibitors Boc-2 and WRW4. The main mechanism involves the activation of AMPK by ANXA1 through FPR2 in order to enhance fatty acid oxidation in cardiomyocytes, thereby ultimately leading to a reduction in lipid accumulation and associated lipotoxicity. Our findings demonstrate that the ANXA1-FPR2 axis plays a protective role in obesity-associated AF by alleviating metabolic stress in the atria of obese mice, thereby emphasizing its potential as a promising therapeutic target for AF.

Keywords: AMP-activated protein kinase; ANXA1-FPR2; Atrial fibrillation; Lipotoxicity; Obesity.

本文使用的产品

小核酸转染试剂Entranster™-R4000

已有 223 篇已发表文献

查看产品详情(含全部 223 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单